Tradestie Institutional Equity Comparison Engine

ZLAB vs CGON โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

CGON Overall Edge

CGON Captures Institutional Edge (3โ€“0 Pillars ยท 5โ€“3 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to CG Oncology, Inc. Common stock (CGON) driven by superior Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, ZLAB trades at N/M Forward P/E with -63.0% operating margin (-6.8% YoY revenue) versus CGON at N/M Forward P/E and -4293.5% operating margin (-3.7% YoY). In options structure, ZLAB sits in UNCLASSIFIED (58th %ile IV; Dealer Gamma Walls on Pro) against CGON sits in CONSOLIDATION (85th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
ZLAB N/M vs CGON N/M Fwd P/E
Growth & Margin Winner CGON
Op Margin -63.0% vs -4293.5% ยท YoY -6.8% vs -3.7%
Momentum & Technical Winner CGON
1Y +9.7% vs +124.9% ยท 52W Pos 60% vs 84%
Options & Structure Winner CGON
UNCLASSIFIED (58th %ile IV) vs CONSOLIDATION (85th %ile IV)
ZLAB NASDAQ
Zai Lab Limited American Depositary Shares
Pharmaceutical Preparations
$23.83
-3.13% 1D
Market Cap $3.0B
1M Return +2.76%
1Y Return +9.66%
Forward P/E N/M
Unified AI Score
47.4 / 100 HOLD
Tech 25.0 Fund 39.0 Flow 50.0 Mom 53.5
CGON NASDAQ
CG Oncology, Inc. Common stock
Biological Products, (No Disgnostic Substances)
$84.94
+14.16% 1D
Market Cap $6.3B
1M Return +41.91%
1Y Return +124.93%
Forward P/E N/M
Unified AI Score
45.0 / 100 HOLD
Tech 15.0 Fund 44.0 Flow 69.0 Mom 60.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: ZLAB +9.66% CGON +124.93% Spread: +115.27 pp (CGON Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
ZLAB TTM Op. Margin: -63.0% CGON TTM Op. Margin: -4293.5%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on ZLAB vs CGON. Trailing 12-month operating profitability (ZLAB -63.0% vs CGON -4293.5%) and valuation multiples (ZLAB N/M vs CGON N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: ZLAB (3) vs CGON (5)
Institutional Metric ZLAB CGON Criterion Row Winner
Market Capitalization Scale $3.0B $6.3B Larger Scale CGON
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth -6.8% -3.7% Higher Growth CGON
Operating Margin (TTM) Profitability -63.0% -4293.5% Higher Margin ZLAB
Net Profit Margin Profitability -44.9% 0.0% Higher Margin CGON
Return on Equity (ROE) Capital Efficiency -30.0% -28.3% Higher ROE CGON
52-Week Range Position Momentum 60% ($16โ€“$29) 84% ($37โ€“$94) Stronger Trend CGON
Beta / 30D Volatility Risk Regime 1.19ฮฒ ยท 78% Vol 0.77ฮฒ ยท 86% Vol Lower Realized Risk ZLAB
Unified Institutional Score Composite Signal 47.4 / 100 (HOLD) 45.0 / 100 (HOLD) Higher Composite ZLAB

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full ZLAB vs CGON Buy Guide
ZLAB UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 58th %ile
IV Regime Balanced (25thโ€“60th %ile)
Live ZLAB Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
CGON CONSOLIDATION
62d in phase ยท OBV ACCUMULATION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 85th %ile
IV Regime Extreme (>80th %ile)
Live CGON Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither ZLAB nor CGON registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.